Item 8.01 Other Events.

On June 24, 2020, Merck & Co., Inc. (the "Company") closed an underwritten public offering of $1,000,000,000 aggregate principal amount of 0.750% Notes due 2026 (the "2026 Notes"), $1,250,000,000 aggregate principal amount of 1.450% Notes due 2030 (the "2030 Notes"), $1,000,000,000 aggregate principal amount of 2.350% Notes due 2040 (the "2040 Notes") and $1,250,000,000 aggregate principal amount of 2.450% Notes due 2050 (the "2050 Notes" and, together with the 2026 Notes, the 2030 Notes and the 2040 Notes, collectively, the "Notes") under the Company's Registration Statement on Form S-3ASR (Registration No. 333-224017).

The Notes are being issued under an indenture dated as of January 6, 2010, between the Company and U.S. Bank Trust National Association, as trustee, a copy of which was attached as Exhibit 4.1 to the Company's Current Report on Form 8-K previously filed with the Securities and Exchange Commission on December 10, 2010 and is incorporated herein by reference. Copies of the officers' certificate for each series of the Notes (including forms of each of the respective Notes attached thereto) pursuant to Section 301 of the indenture governing the Notes are attached hereto as exhibits 4.1, 4.2, 4.3 and 4.4 and are incorporated herein by reference. The legal opinion related to these Notes is attached hereto as Exhibit 5.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits

  Exhibit 4.1         0.750% Notes due 2026 Officers' Certificate of the Company
                    dated June 24, 2020, including form of the 2026 Notes.

  Exhibit 4.2         1.450% Notes due 2030 Officers' Certificate of the Company
                    dated June 24, 2020, including form of the 2030 Notes.

  Exhibit 4.3         2.350% Notes due 2040 Officers' Certificate of the Company
                    dated June 24, 2020, including form of the 2040 Notes.

  Exhibit 4.4         2.450% Notes due 2050 Officers' Certificate of the Company
                    dated June 24, 2020, including form of the 2050 Notes.

  Exhibit 5.1         Opinion and Consent of Jennifer Zachary, Esq., Executive Vice
                    President, General Counsel and Corporate Secretary of the
                    Company.

  Exhibit 23.1        Consent of Jennifer Zachary, Esq., Executive Vice President,
                    General Counsel and Corporate Secretary of the Company (contained
                    in Exhibit 5.1 to this Current Report on Form 8-K).

  Exhibit 104       Cover Page Interactive Data File (embedded within the Inline XBRL
                    document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses